Italy’s pharmaceutical manufacturer Fidia Farmaceutici S.p.A. sells in Romania medicines, food supplements, and medical devices exclusively through Fidia Farmaceutici S.p.A. and Fidia Pharma Romania SRL.
Meditrina Pharmaceuticals S.R.L., part of the Synapsis-Meditrina pharmaceutical group, is the sole distributor in Romania of the products in its portfolio, namely human-use medicines, medical devices, food supplements, and dermato-cosmetics.
Following its assessment, the Competition Council found that the transaction does not raise significant obstacles to effective competition on the Romanian market or on a substantial part of it, and that there are no serious doubts regarding its compatibility with a normal competitive environment.
The decision will be published on the website of the national competition authority after the removal of confidential information.